Shubhi Garg

Drag to reposition cover

Shubhi Garg
Share :Shubhigarg12

Dentist and a healthcare researcher

Details
7 posts
Male
05-12-98
Living in India
Located in Lucknow

Photos

created a new article

6 w

PLK1 Inhibitors for Refractory and Relapsed Cancer Patients | #plk1

PLK1 Inhibitors for Refractory and Relapsed Cancer Patients

PLK1 inhibitors are increasingly being recognized as a promising treatment option for refractory and relapsed cancer patients. With a growing PLK1 inhibitors pipeline and encouraging clinical trial data, these therapies are poised to become a significant component of cancer treatment regim

$PLK1 Inhibitors for Refractory and Relapsed Cancer Patients$

Comment

5000

created a new article

6 w

Pediatric Applications of BTK Inhibitors: Potential and Challenges | #btk

Pediatric Applications of BTK Inhibitors: Potential and Challenges

While the application of BTK inhibitors in pediatric oncology is still emerging, their potential to improve outcomes for children with hematologic cancers is promising. With continued research and clinical trials, these therapies could become a valuable addition to pediatric cancer treatme

Comment

5000

created a new article

6 w

Adoption of BCMA Therapies in Emerging Markets | #bcma

Adoption of BCMA Therapies in Emerging Markets

The adoption of BCMA therapies in emerging markets is gaining momentum as countries invest in healthcare infrastructure and establish supportive policies. As more partnerships are formed and innovative pricing strategies are implemented, emerging markets are expected to play a growing role

Comment

5000

created a new article

6 w

Patient Access to CDK 7 Inhibitors in Emerging Markets | #cdk-7

Patient Access to CDK 7 Inhibitors in Emerging Markets

While the adoption of CDK 7 inhibitors in emerging markets presents several challenges, strategic initiatives to improve access, affordability, and healthcare infrastructure could help extend the benefits of these innovative therapies to patients in need.

Comment

5000

created a new article

6 w

Patient Access to AKT Inhibitors: Market Barriers and Opportunities | #akt Inhibitor

Patient Access to AKT Inhibitors: Market Barriers and Opportunities

While barriers to access remain, ongoing advancements in AKT inhibitor pipeline developments, more efficient patient identification, and policy adjustments offer promising opportunities to improve access to these life-saving therapies.

Comment

5000

Load more posts

Photos

6 w

PLK1 Inhibitors for Refractory and Relapsed Cancer Patients

6 w

Pediatric Applications of BTK Inhibitors: Potential and Challenges

6 w

Adoption of BCMA Therapies in Emerging Markets

6 w

Patient Access to CDK 7 Inhibitors in Emerging Markets

6 w

Patient Access to AKT Inhibitors: Market Barriers and Opportunities

Following 20

Followers 14

Likes 0

Groups 0